Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine TrialsAlfredo J Mena Lora, Catherine Orrel, Jessica E. Long et al.|JAMA Network Open|2023Cited by 38
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBDHang Ma, Jianwei Zhu, Zhenyu Wang et al.|Cell Discovery|2022Cited by 24
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variantsXiangyang Chi, Qiang Zhou, Lingyun Xia et al.|Cell Discovery|2023Cited by 17